Company / Gross Profit per Share
Haemonetics Gross Profit per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$14.34
FY2026
5-year range
$11.96 / $14.85
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#35 of 99
Health Care
What the data says
At $14.34, Haemonetics's gross profit per share ranks #35 of 99 in the Health Care sector. Gross Profit per Share has fluctuated over the past 9 years, ranging from $7.76 in FY2020 to $14.85 in FY2024.
Based on SEC 10-K filings.
14.34 in FY2026 with a 5-year CAGR of +7.8%.
Improved from $13.46 to $14.34 over the past 3 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Sector benchmark
#35 of 99 in Health CareTop 35% of 99This company $14.34 Sector average $13.98
▼
+2.6% above sector average
Key checks
Key Insights
- Ranks #35 out of 99 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2024.
- Lowest gross profit per share in the period was in FY2020.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $14.34 | - |
| FY2025 | - | - |
| FY2024 | $14.85 | +10.3% |
| FY2023 | $13.46 | +12.5% |
| FY2022 | $11.96 | +21.5% |
| FY2021 | $9.84 | +26.9% |
| FY2020 | $7.76 | -17.1% |
| FY2019 | $9.35 | +17.0% |
| FY2018 | $7.99 | -1.2% |
| FY2017 | $8.09 | +10.4% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026